logo
Select company
Select metric
$ 1.68MStock Based Compensation
VS
Market
75
Sector
79
Industry
80
History
49
$ 0.47Close
$ 0.27 - $ 3.09 52-Week Range
Ticker Information

Ticker

MBRX

Company Name

MOLECULIN BIOTECH INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MOLECULIN BIOTECH INC - Stock Based Compensation Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MBRX - SB Comp. Historical data
DateStock Based Compensation
6/30/2025$ 1.68M
3/31/2025$ 1.72M
12/31/2024$ 1.73M
9/30/2024$ 1.78M
6/30/2024$ 1.92M
3/31/2024$ 1.98M
12/31/2023$ 1.98M
9/30/2023$ 2.04M
6/30/2023$ 2.25M
3/31/2023$ 2.25M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Stock Based Compensation

[Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].

MBRX - Stock Based Compensation, Last 5 years

$ 1.65M

Minimum

Sep 30, 2020

$ 2.58M

Maximum

Jun 30, 2022

$ 2.01M

Average

$ 1.98M

Median

SB Comp. Benchmark Analysis

The chart above depicts the distribution of SB Comp. for companies in the Total Stock Market. The average SB Comp. of the companies is $ 12.15M with a standard deviation of $ 14.38M.
The following table provides additional summary stats:
SB Comp. in the Market:
filtered constituents3.51K
min$ -20.28M
max$ 59.43M
average$ 12.15M
median$ 6.38M
std$ 14.38M